Sensitivity of the Quantiferon-Gold in-tube assay in sputum smear positive TB cases in Indonesia

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Rutherford, Merrin ^a   Alisjahbana, Bachti ^b   Maharani, Winni ^b   Sampurno, Hedy ^c   van Crevel, Reinout ^d   Hill, Philip C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c Bandung Community Lung Clinic   (Indonesia)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; HUMAN; INDONESIA; MAJOR CLINICAL STUDY; MALE; QUANTIFERON GOLD IN TUBE ASSAY; RISK FACTOR; SENSITIVITY ANALYSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; LATENT TUBERCULOSIS; MICROBIOLOGY; MIDDLE AGED; SPUTUM; STANDARD;

ADOLESCENT; ADULT; DIAGNOSTIC TECHNIQUES AND PROCEDURES; FEMALE; HUMANS; INDONESIA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; REFERENCE STANDARDS; SPUTUM; TUBERCULIN TEST; YOUNG ADULT;

EID: 77957814611     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012020     Document Type: Article

References (20)

1. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, et al. (2010) Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 375: 1814-1829.
2. Falk A, Fuchs GF (1978) Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration Cooperative Study XII. Chest 73: 44-48.
3. Veening GJ (1968) Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults. Bull Int Union Tuberc 41: 169-171.
4. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, et al. (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54: 49-55.
5. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-184.
6. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356: 1099-1104.
7. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, et al. (2007) Prospective comparison of the tuberculin skin test and 2 whole-blood interferongamma release assays in persons with suspected tuberculosis. Clin Infect Dis 45: 837-845.
8. Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, et al. (2006) Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol 44: 2844-2850.
9. Adetifa IM, Ota MO, Jeffries DJ, Hammond A, Lugos MD, et al. (2010) Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia. Pediatr Infect Dis J 29: 439-443.
10. Organization WH (2008) Global Tuberculosis Control. Surveillance, Planning, Financing. Geneva: World Health Organization.
11. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July (1999) This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 161: 1376-1395.
12. Pai M, Joshi R, Bandyopadhyay M, Narang P, Dogra S, et al. (2007) Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 35: 98-103.
13. Adetifa IM, Lugos MD, Hammond A, Jeffries D, Donkor S, et al. (2007) Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis 7: 122.
14. Miranda C, Yen-Lieberman B, Terpeluk P, Tomford JW, Gordon S (2009) Reducing the rates of indeterminate results of the QuantiFERON-TB Gold In- Tube test during routine preemployment screening for latent tuberculosis infection among healthcare personnel. Infect Control Hosp Epidemiol 30: 296-298.
15. Herrera V, Yeh E, Murphy K, Parsonnet J, Banaei N (2010) Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J Clin Microbiol.
16. Bartu V, Havelkova M, Kopecka E (2008) QuantiFERON-TB Gold in the diagnosis of active tuberculosis. J Int Med Res 36: 434-437.
17. Dewan PK, Grinsdale J, Kawamura LM (2007) Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 44: 69-73.
18. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, et al. (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54: 49-55.
19. Park SY, Jeon K, Um SW, Kwon OJ, Kang ES, et al. (2009) Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis. Scand J Infect Dis 41: 818-822.
20. Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, et al. (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45: 428-435.